Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GALECTIN THERAPEUTICS INC | Director | Common Stock | 75K | $178K | $2.38 | Jun 20, 2024 | By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC |
GALECTIN THERAPEUTICS INC | Director | Common Stock | 28.5K | $67.8K | $2.38 | Jun 20, 2024 | Direct |
GALECTIN THERAPEUTICS INC | Director | Common Stock | 18.1K | $43K | $2.38 | Jun 20, 2024 | IRA |
GALECTIN THERAPEUTICS INC | Director | Stock Option (right to buy) | 50K | Jan 24, 2024 | Direct |